From (epi)genomics of diabetes to precision medicine

Version imprimable
July 28, 2017
Philippe Froguel

For the CRCHUM conference taking place on August 11, 2017, Philippe Froguel, Director of the European Genomic Institute for Diabetes, will discuss his recent research project linked to diabetes.


Professor Philippe Froguel is an endocrinologist, a geneticist, and a researcher. He is professor at Imperial College London, and at Lille 2 University. In Lille, he directs the European Genomic Institute for Diabetes. Since discovering glucokinase, the first gene found to be involved in a monogenetic form of diabetes, Professor Froguel has made major contributions to the understanding of the genetic basis of diabetes and of obesity. In the field of diabetes, he is one of the world’s most frequently cited authors. 

Guest of Vincent Poitout, Cardiometabolic theme.

This conference will be presented in English.

Friday, August 11, 2017, at Noon.
Auditorium of the CRCHUM, R05.210 and R05.220
900 Saint-Denis Street, 5th floor
Montreal (Quebec)  H2X 0A9

Philippe Froguel, M.D. 
Director, European Genomic Institute for Diabetes (E.g.i.d.)
Professor, Imperial College London and Lille 2 University

About CRCHUM Conferences

The CRCHUM Conferences are free weekly meetings featuring renowned scientific speakers from various disciplines. These conferences are accredited by the Royal College of Physicians and Surgeons of Canada as continuing professional development activities. The CRCHUM conferences are made possible thanks to the financial support of our partners: AstraZeneca, GSK, Lilly, Merck, Roche & Servier.

About our scientific activities

Schedule of scientific activities at the CRCHUM